Recombinant Plasma Protein Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 10
SKU : PH1275
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Projected CAGR value of the Recombinant Plasma Protein Therapeutics Market ?
Recombinant Plasma Protein Therapeutics Market is expected to grow at a high CAGR during the forecast period 2024-2031.
Who are the key players in Recombinant Plasma Protein Therapeutics Market ?
Major players are CSL Limited, Takeda Pharmaceutical Company Limited, Octapharma, Novo Nordisk A/S, Bayer AG, Sanofi, Aptevo Therapeutics, Pharma Group NV, Pfizer Inc, Viropharma Biologics, Inc, Grifols S.A, Biotest AG, Baxter and Kedrion SPA.
Related Reports
pharmaceuticalsPlasma Protein Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 25
Starting from
$4350
pharmaceuticalsProtein Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 February 29
Starting from
$4350
pharmaceuticalsPneumonia Therapeutics Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 11
Starting from
$4350